Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05784922 · ClinicalTrials.gov registry record
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
A clinical trial of Lung Cancer and Smoking Behaviors, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05784922: Recruiting study of Lung Cancer and Smoking Behaviors, sponsored by Massachusetts General Hospital.
NCT05784922 is a study of Lung Cancer and Smoking Behaviors that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 2,000 participants, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05784922, a study of Lung Cancer and Smoking Behaviors, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to promote lung cancer screening (LCS) uptake among Hispanic current and former smokers. The main questions it aims to answer are: * What barriers do current and former Hispanic smokers face in the identification and documentation of their smoking status? * How can digital delivery of an educational video promote LCS uptake among current and former Hispanic smokers? Participants will receive an educational video about lung cancer screening and complete brief, self-reported surveys afterwards.
Primary Outcome
Reach is defined as \>20% of enrolled participants interacting with the digital delivery of the LCS educational video (i.e., partial or complete review of the LCS educational video).
Conditions Studied
Interventions
- OTHER Educational Lung Cancer Screening (LCS) Video
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2023-02-03 |
| Est. Completion | 2028-01-31 |
What NCT05784922 shows while recruiting
NCT05784922 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (115% higher).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational Lung Cancer Screening (LCS) Video is the first listed.
NCT05784922 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05784922 about?
NCT05784922 is a clinical study titled "Health Opportunities and Promoters of Equitable Screening for Lung Cancer". The goal of this clinical trial is to promote lung cancer screening (LCS) uptake among Hispanic current and former smokers. The main questions it aims to answer are: * What barriers do current and former Hispanic smokers face in the identification and documentation of their smoking status? * How ca...
What is the current status of trial NCT05784922?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2023-02-03. Estimated completion is 2028-01-31.
What conditions does trial NCT05784922 study?
This clinical trial studies the following conditions: Lung Cancer, Smoking Behaviors, Diagnosis.
What interventions are being tested in trial NCT05784922?
The interventions under investigation include: Educational Lung Cancer Screening (LCS) Video (OTHER).
Who is sponsoring clinical trial NCT05784922?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05784922 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05784922's enrollment target sits among peer trials
2,000 28th of 409 higher than 380 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI